Drug Delivery and Targeting [E-Book] / edited by Monika Schäfer-Korting, Ulrich S. Schubert.
Since the publication of the Handbook of Experimental Pharmacology Vol. 197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. This is in particular relevant with the new generation of drugs acting on the immune system and tumors. Thes...
Saved in:
|
Full text |
|
| Personal Name(s): | Schäfer-Korting, Monika, editor |
| Schubert, Ulrich S., editor | |
| Edition: |
1st edition 2024. |
| Imprint: |
Cham :
Springer,
2024
|
| Physical Description: |
X, 411 pages 70 illustrations (online resource) |
| Note: |
englisch |
| ISBN: |
9783031528644 |
| DOI: |
10.1007/978-3-031-52864-4 |
| Series Title: |
Handbook of Experimental Pharmacology ;
284 |
| Subject (LOC): |
- Part I. Nanoparticles and other Advanced Technologies
- Knowledge-based design of multi-functional polymer-based nanoparticles
- Stimuli-responsive non-viral nanoparticles for gene delivery
- Sustainability in drug and nano-particle processing
- Advanced formulation approaches for proteins
- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids
- Advances in vaccine delivery enhancers - small molecules and nanomaterials
- Biodegradable long acting injectables: Platform technology and industrial challenges
- Part II. Visualization Technologies
- Visualization of Nano-carriers and Drugs in Cells and Tissue
- Characterization of drug delivery systems by transmission electron microscopy
- Part III. Target Specific Delivery
- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders
- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints
- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism
- Molecular therapeutics for pulmonary diseases - the need for drug targeting
- Delivery of mitochondrial RNA
- Part IV. Concerted Actions - Thinking the Drug from the Beginning
- ATMP formulations and delivery
- Preclinical testing and approval of ATMP
- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases.